Myung In Pharmaceutical LTD. (KRX:317450)
South Korea · Delayed Price · Currency is KRW 56,900
+600 (1.07%)
At close: Apr 8, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 830.74 billion as of April 8, 2026.
Market Cap
830.74B
Enterprise Value
322.43B
Revenue
287.25B
Ranking
n/a
PE Ratio
8.47
Stock Price
56,900.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 830.74B, a decrease of -53.32%. That is a compound annual growth rate of -77.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 830.74B | -17.42% |
| Dec 30, 2025 | 1.01T | -43.48% |
| Oct 1, 2025 | 1.78T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.08T |
| Samyang Biopharm | 600.82B |
| ImmuneOncia Therapeutics | 559.95B |
| HEM Pharma | 486.96B |
| CellBion | 381.74B |
| DAE HWA Pharmaceutical | 245.76B |
| GREEN CROSS WellBeing | 242.75B |
| NOVAREX | 235.26B |